GlassScriptPhysician profile
Vincent James Sammarco
NPI 1174593479
$361,311.63
in general payments reported to CMS, 2019-2025
17 companies · $23K in 2025
The $23K reported for 2025 was more than what 91% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81K · 2020: $56K · 2021: $55K · 2022: $53K · 2023: $44K · 2024: $50K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $73K · Consulting Fee: $36K · Travel and Lodging: $5,422 · Food and Beverage: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $72,853.00 |
| Consulting Fee | $36,175.00 |
| Travel and Lodging | $5,421.74 |
| Food and Beverage | $2,145.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $329,911.72 | 2019-2025 | Io Fix, Axis, Ex Fix |
| Medical Device Business Services, INC. | $15,938.79 | 2019 | |
| Integra Lifesciences Corporation | $7,840.26 | 2019 | |
| Ascension Orthopedics, INC. | $2,516.00 | 2019 | |
| Synthes USA Products LLC | $1,263.44 | 2019 | |
| Legacy Ortho LLC | $1,068.33 | 2024 | |
| Stryker Corporation | $874.44 | 2021-2025 | Prophecy, Pangea, Ortholoc 3di |
| Arthrex, INC. | $471.35 | 2024 | |
| Depuy Synthes Sales INC. | $436.56 | 2020-2025 | Monovisc, Orthovisc, Dynaforce |
| Treace Medical Concepts, INC. | $243.36 | 2023 | |
| Arteriocyte Medical Systems, INC. | $183.24 | 2025 | Magellan |
| Biotissue Holdings INC. | $136.34 | 2024 | |
| Ossio INC | $128.25 | 2021 | |
| Wright Medical Technology, INC. | $125.00 | 2019 | |
| Paragon 28, INC. | $95.47 | 2019-2023 | Monster |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $57.71 | 2023 | |
| Vericel Corporation | $21.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Sammarco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.